Stockreport

Tenaya Therapeutics: Risky But Promising Cardiac Gene Platform [Seeking Alpha]

Tenaya Therapeutics, Inc.  (TNYA) 
PDF They have TN-201 for HCM, TN-401 for ARVC, and HDAC6 inhibitor TN-301. Management positions its AAV9 platform and internal manufacturing as a reusable engine for multi [Read more]